Science
Mechanism of Action
This extract operates through several key compounds. Allantoin promotes epidermal regeneration and wound healing, concurrently delivering soothing and anti-irritant actions. Rosmarinic acid and other phenolic compounds exert antioxidant and anti-inflammatory effects by modulating the NF-κB signaling pathway, which reduces pro-inflammatory markers. Natural mucilage acts as a humectant, enhancing moisture retention, while tannins provide astringent properties to refine skin texture and minimize pore appearance.
Research
Clinical Evidence
Medium confidence5-10%
Key findings
- 01 Studies recommend a 5-10% concentration for soothing, anti-irritant, antioxidant, and mild keratinolytic effects in skin and hair care formulations.
- 02 Clinical trials involving 10-20% comfrey root extract creams demonstrated significant pain reduction, decreased stiffness, and improved function in individuals with knee osteoarthritis.
- 03 Specific liquid extract formulations, such as 35 g liquid extract (DER 1:2) in 100 g cream or 10 g liquid extract (DER 2:1) in 100 g ointment, have been employed topically for painful joints, bruises, and sprains, with recommended treatment durations of up to 21 or 10 days, respectively.
Transparency
Dusting Analysis
Effective cosmetic applications typically require Symphytum Officinale Root Extract at a concentration of 5% or higher to deliver its noted soothing, antioxidant, and regenerative benefits. Formulations containing less than 5% may not achieve the desired clinical impact.
The Formula
Formulation
Conflicts
- Must not be applied to broken or compromised skin due to potential systemic absorption of pyrrolizidine alkaloids (PAs).
- Its use is highly controversial due to the presence of hepatotoxic and potentially carcinogenic pyrrolizidine alkaloids. Formulations must exclusively utilize certified PA-free extracts or strictly adhere to stringent usage limits and application durations established by regulatory bodies.
Safety
Safety Profile
The Cosmetic Ingredient Review Expert Panel has not evaluated the safety of Symphytum officinale extract. This ingredient is contentious primarily due to naturally occurring pyrrolizidine alkaloids (PAs), which are linked to liver toxicity and potential carcinogenicity, particularly with internal exposure and high topical concentrations. The FDA advises against dietary supplements containing comfrey due to these risks. For topical application, global regulatory guidelines vary, with some jurisdictions imposing strict limits. For instance, in Germany, the permissible daily topical dose for PAs is 100 μg, with treatment restricted to 4-6 weeks annually if the daily dose ranges from 10-100 μg. It is critically important that this extract is only applied to intact skin, and formulations should ideally utilize certified PA-free versions to mitigate health risks.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its demonstrated soothing, regenerative, and anti-inflammatory benefits, Symphytum Officinale Root Extract is deemed unsuitable for general cosmetic use due to the significant risk of pyrrolizidine alkaloid toxicity, necessitating its exclusion from formulations for a precision skincare brand.
Related
Similar Ingredients
Finding similar ingredients…